Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00115180 · ClinicalTrials.gov registry record

Racial and Ethnic Disparities in Acute Pain Control

A clinical trial, sponsored by Agency for Healthcare Research and Quality (AHRQ).

Completed
Registry status
285
Enrollment target

NCT00115180: Completed study, sponsored by Agency for Healthcare Research and Quality (AHRQ).

NCT00115180 is a clinical trial that has completed, run by Agency for Healthcare Research and Quality (AHRQ). The registered enrollment target is 285 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00115180 has completed, sponsored by Agency for Healthcare Research and Quality (AHRQ).

COMPLETED
Registry status
285 participants
Enrollment target

Study Summary

We aim to compare pain management among three groups of ethnic disparity (ED) patients, Hispanics, non-Hispanic Blacks, non-Hispanic Whites, and assess whether the observed association between pain management and race/ethnicity is independent of potentially important confounding variables (e.g., age, sex, insurance status, education). We also aim to assess whether the effect of race/ethnicity on adequacy of pain management is explained by patients' initial pain intensity or by discordance between patient and physician's: a) race/ethnicity; b) perception of patient's pain. To do this 285 patients with long-bone fractures will be recruited in the EDs of one municipal and one voluntary hospital serving an inner-city, disadvantaged population in the Bronx. Data will be collected on pain using self-reported pain and non-verbal pain expressions at baseline, one hour post-baseline, and discharge. Data on analgesics administered, patient and physician characteristics will also be collected. We plan to conduct a chart review of long bone fractures in 2000 and 2001 so that we can analyze the association between race/ethnicity and pain management using the same design as published studies. Comparison of the retrospective and prospective studies will strengthen inferences that can be drawn. We hypothesize that Black and Hispanic patients will be less likely to receive opioid analgesics than white patients.

Primary Outcome

The names of all medications, dose, route, and time administered were obtained in real time from the chart and ED staff. Patients were categorized as receiving: 1) no analgesics; 2) NSAIDS or acetaminophen; or 3) opioids. If both NSAIDS or acetaminophen and opioids were administered, patients were categorized as having received opioids. Analgesics given solely for fracture reduction were not used to categorize patients. Opioid analgesics were transformed into morphine equivalents as follows: 1 m

Interventions

  • OTHER No intervention

Trial Details

FieldValue
Enrollment Target 285 participants
Start Date 2003-09
Est. Completion 2006-11

What the finished NCT00115180 record still lists

NCT00115180 is an observational study that tracks outcomes without assigning an intervention. The registered 285 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.

NCT00115180 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00115180 about?

NCT00115180 is a clinical study titled "Racial and Ethnic Disparities in Acute Pain Control". We aim to compare pain management among three groups of ethnic disparity (ED) patients, Hispanics, non-Hispanic Blacks, non-Hispanic Whites, and assess whether the observed association between pain management and race/ethnicity is independent of potentially important confounding variables (e.g., age...

What is the current status of trial NCT00115180?

This trial is currently completed. The enrollment target is 285 participants. The study started on 2003-09. Estimated completion is 2006-11.

What interventions are being tested in trial NCT00115180?

The interventions under investigation include: No intervention (OTHER).

Who is sponsoring clinical trial NCT00115180?

This trial is sponsored by Agency for Healthcare Research and Quality (AHRQ), which has 20 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03412877 · 285 participants · Phase 2

    Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

  • NCT04537936 · 285 participants · NA

    Psychotherapy Intervention for Latinos With Adv Cancer

  • NCT04965675 · 285 participants · Phase 3

    A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine

  • NCT05320835 · 285 participants · NA

    A Setting Focus Overdose Prevention Intervention

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00115180, the US trial registry maintained by the National Library of Medicine. NCT00115180 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.